吉西他滨
胶质母细胞瘤
纳米载体
自愈水凝胶
医学
药物输送
药理学
脑瘤
癌症研究
药品
纳米医学
化学
化疗
病理
内科学
材料科学
纳米技术
纳米颗粒
有机化学
作者
Chiara Bastiancich,Laurent P. Lemaire,John I. Bianco,Florence Franconi,Fabienne Danhier,Véronique Préat,Guillaume Bastiat,Frédéric Lagarce
出处
期刊:Nanomedicine
[Future Medicine]
日期:2018-08-01
卷期号:13 (16): 1999-2013
被引量:58
标识
DOI:10.2217/nnm-2018-0057
摘要
Aim: Anticancer drug-loaded hydrogels are a promising strategy for the local treatment of incurable brain tumors such as glioblastoma (GBM). Recently, we demonstrated the efficacy of lauroyl-gemcitabine lipid nanocapsule hydrogel (GemC12-LNC) in a U-87 MG xenograft orthotopic mouse model. In this study, we developed a reliable and reproducible surgical procedure to resect orthotopic GBM tumors in rats. GemC12-LNC hydrogel integrity was tested after brain administration in rats and its anti-tumor efficacy was tested on a 9L syngeneic orthotopic model. Results: We demonstrated that LNC integrity is maintained at least for one week after local administration of GemC12-LNC. GemC12-LNC was able to delay the formation of recurrences in 9L tumor-bearing resected rats, demonstrating the efficacy of this nanomedicine hydrogel in this preclinical model. Conclusion: Our results confirm that GemC12-LNC, a hydrogel uniquely formed by a nanocarrier and a cytotoxic drug, could be a promising and safe delivery tool for the local treatment of operable GBM tumors.
科研通智能强力驱动
Strongly Powered by AbleSci AI